Euromedis Groupe SA (ALEMG) - Cash Flow Conversion Efficiency

Latest as of June 2024: 0.036x

Based on the latest financial reports, Euromedis Groupe SA (ALEMG) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€796.00K ≈ $930.61K USD) by net assets (€22.06 Million ≈ $25.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Euromedis Groupe SA - Cash Flow Conversion Efficiency Trend (2009–2022)

This chart illustrates how Euromedis Groupe SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Euromedis Groupe SA debt and liabilities for a breakdown of total debt and financial obligations.

Euromedis Groupe SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Euromedis Groupe SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Millennium Pharmacon International
JK:SDPC
-0.062x
Les Hôtels de Paris SA
PA:HDP
-0.102x
RECYCLICO BATTERY METALS
F:ID4
N/A
MSCM Holdings Bhd
KLSE:0041
-0.048x
Turbo Mech Bhd
KLSE:5167
0.025x
Bodycote PLC
LSE:BOY
0.096x
Iconic Minerals Ltd
V:ICM
-2.148x
Marvel Gold Ltd
AU:MVL
-0.291x

Annual Cash Flow Conversion Efficiency for Euromedis Groupe SA (2009–2022)

The table below shows the annual cash flow conversion efficiency of Euromedis Groupe SA from 2009 to 2022. For the full company profile with market capitalisation and key ratios, see ALEMG market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 €34.88 Million
≈ $40.78 Million
€-1.05 Million
≈ $-1.23 Million
-0.030x -106.44%
2021-12-31 €41.24 Million
≈ $48.21 Million
€19.25 Million
≈ $22.50 Million
0.467x +34.56%
2020-12-31 €38.93 Million
≈ $45.51 Million
€13.50 Million
≈ $15.79 Million
0.347x +534.61%
2019-12-31 €17.66 Million
≈ $20.64 Million
€965.00K
≈ $1.13 Million
0.055x +171.22%
2018-12-31 €21.26 Million
≈ $24.86 Million
€-1.63 Million
≈ $-1.91 Million
-0.077x -274.87%
2017-12-31 €27.80 Million
≈ $32.50 Million
€1.22 Million
≈ $1.43 Million
0.044x -12.74%
2016-12-31 €28.81 Million
≈ $33.68 Million
€1.45 Million
≈ $1.69 Million
0.050x -44.13%
2015-12-31 €28.60 Million
≈ $33.44 Million
€2.58 Million
≈ $3.01 Million
0.090x -33.19%
2014-12-31 €25.58 Million
≈ $29.91 Million
€3.45 Million
≈ $4.03 Million
0.135x +31.20%
2013-12-31 €23.42 Million
≈ $27.38 Million
€2.40 Million
≈ $2.81 Million
0.103x -53.88%
2012-12-31 €21.25 Million
≈ $24.85 Million
€4.73 Million
≈ $5.53 Million
0.223x +419.33%
2011-12-31 €20.18 Million
≈ $23.59 Million
€865.00K
≈ $1.01 Million
0.043x -80.00%
2010-12-31 €18.35 Million
≈ $21.46 Million
€3.93 Million
≈ $4.60 Million
0.214x +166.57%
2009-12-31 €17.52 Million
≈ $20.49 Million
€-5.64 Million
≈ $-6.60 Million
-0.322x --

About Euromedis Groupe SA

PA:ALEMG France Medical Distribution
Market Cap
$15.56 Million
€13.31 Million EUR
Market Cap Rank
#26016 Global
#436 in France
Share Price
€4.68
Change (1 day)
+0.86%
52-Week Range
€3.58 - €4.94
All Time High
€24.90
About

Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more